Ricci Joseph A, Epstein Sherise, Momoh Adeyiza O, Lin Samuel J, Singhal Dhruv, Lee Bernard T
Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Section of Plastic Surgery, University of Michigan Medical School, Ann Arbor, Michigan.
J Surg Res. 2017 Oct;218:108-116. doi: 10.1016/j.jss.2017.05.072. Epub 2017 Jun 15.
Implant-based breast reconstruction is the most common type of reconstruction after postmastectomy radiation therapy (PMRT). The impact of the timing of PMRT to a tissue expander or permanent implant is not well understood. The purpose of this systematic review was to evaluate outcomes in implant-based reconstruction and the timing of PMRT.
A review of the English literature in the PubMed/MEDLINE database (2000-2016) was performed to identify all articles on implant-based breast reconstruction and PMRT. Cases from each study were grouped by PMRT to a tissue expander or PMRT to a permanent implant. Outcomes of interest included reconstructive failure and capsular contracture as overall rates and associations were pooled. Effect sizes (z values), risk ratios (RRs), and heterogeneity scores (I) were calculated on meta-analysis.
There were 20 studies meeting inclusion criteria with 2348 patients identified. Pooled analysis revealed an overall rate of reconstructive failure of 17.6% and Baker grade III/IV capsular contracture of 37.5%. PMRT applied to tissue expanders resulted in higher rates of reconstructive failure compared with PMRT applied to permanent silicone implants (20% versus 13.4%, RR = 2.33, P = 0.0083, 95% confidence interval 1.24-4.35), but lower rates of capsular contracture (24.5% versus 49.4%, RR = 0.53, P = 0.083, 95% confidence interval 0.26-1.09).
Regardless of timing, PMRT applied to implant-based breast reconstruction was associated with high risk of reconstructive failure and capsular contracture. Surgeons should consider alternative strategies, such as autologous tissue reconstructions, in patients requiring PMRT.
基于植入物的乳房重建是乳房切除术后放疗(PMRT)后最常见的重建类型。PMRT应用于组织扩张器或永久性植入物的时机影响尚不清楚。本系统评价的目的是评估基于植入物的重建效果及PMRT的时机。
检索PubMed/MEDLINE数据库(2000 - 2016年)中的英文文献,以识别所有关于基于植入物的乳房重建和PMRT的文章。每项研究中的病例按PMRT应用于组织扩张器或PMRT应用于永久性植入物进行分组。感兴趣的结局包括重建失败和包膜挛缩的总体发生率,并汇总相关性。在荟萃分析中计算效应量(z值)、风险比(RRs)和异质性得分(I)。
有20项研究符合纳入标准,共纳入2348例患者。汇总分析显示,重建失败的总体发生率为17.6%,贝克III/IV级包膜挛缩的发生率为37.5%。与PMRT应用于永久性硅胶植入物相比,PMRT应用于组织扩张器导致更高的重建失败率(20%对13.4%,RR = 2.33,P = 0.0083,95%置信区间1.24 - 4.35),但包膜挛缩率较低(24.5%对49.4%,RR = 0.53,P = 0.083,95%置信区间0.26 - 1.09)。
无论时机如何,PMRT应用于基于植入物的乳房重建均与较高的重建失败和包膜挛缩风险相关。对于需要PMRT的患者,外科医生应考虑替代策略,如自体组织重建。